Literature DB >> 3486284

Interleukin 1 stimulation of synovial cell plasminogen activator production.

E Mochan, J Uhl, R Newton.   

Abstract

Addition of human monocyte interleukin 1 (IL-1) to cultured human synovial cells can cause an increase in both cell associated (30-fold) and extracellular (40-fold) plasminogen activator (PA) activity. This increase was inhibited by antibody directed against IL-1 and phenylglyoxal. PA activity could be detected 3 h after the addition of IL-1, continued to increase for 24 h and was dependent on RNA and protein synthesis. The molecular weight of the PA produced from the IL-1 stimulated synovial cells was 55,000 +/- 1,000. Mononuclear cell conditioned media (MCCM) also stimulated synovial cells to produce PA. This stimulation was partly inhibited by anti-IL-1 thus suggesting the presence of appreciable IL-1 activity in MCCM. These results could provide clues as to how immune events are linked to cartilage destruction associated with rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3486284

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  11 in total

1.  Effects of recombinant human IL-1 beta on production of prostaglandin E2, leukotriene B4, NAG, and superoxide by human synovial cells and chondrocytes.

Authors:  T Tawara; M Shingu; M Nobunaga; T Naono
Journal:  Inflammation       Date:  1991-04       Impact factor: 4.092

2.  Identification of a cytokine-induced repressor of interleukin-1 stimulated expression of stromelysin 1 (MMP-3).

Authors:  R C Borghaei; C Sullivan; E Mochan
Journal:  J Biol Chem       Date:  1999-01-22       Impact factor: 5.157

3.  The precursor of a metalloendopeptidase from human rheumatoid synovial fibroblasts. Purification and mechanisms of activation by endopeptidases and 4-aminophenylmercuric acetate.

Authors:  Y Okada; E D Harris; H Nagase
Journal:  Biochem J       Date:  1988-09-15       Impact factor: 3.857

Review 4.  Cytokine-mediated proteolysis in tissue remodelling.

Authors:  S Masure; G Opdenakker
Journal:  Experientia       Date:  1989-06-15

5.  Inhibition of collagen synthesis by interleukin-1 in three-dimensional collagen lattice cultures of fibroblasts.

Authors:  P Gillery; F Coustry; J P Pujol; J P Borel
Journal:  Experientia       Date:  1989-01-15

6.  Interleukin-1 beta prevents the stimulatory effect of transforming growth factor-beta on collagen gene expression in human skin fibroblasts.

Authors:  J Heino; T Heinonen
Journal:  Biochem J       Date:  1990-11-01       Impact factor: 3.857

7.  Human recombinant interleukin-1 regulates cellular mRNA levels of dermatan sulphate proteoglycan core protein.

Authors:  J Heino; V M Kähäri; A Mauviel; T Krusius
Journal:  Biochem J       Date:  1988-05-15       Impact factor: 3.857

8.  Interleukin-4 suppression of interleukin-1-induced transcription of collagenase (MMP-1) and stromelysin 1 (MMP-3) in human synovial fibroblasts.

Authors:  R C Borghaei; P L Rawlings; E Mochan
Journal:  Arthritis Rheum       Date:  1998-08

9.  Effect of antiinflammatory drugs on human interleukin-1-induced cartilage degradation.

Authors:  E C Arner; L R Darnell; M A Pratta; R C Newton; N R Ackerman; W Galbraith
Journal:  Agents Actions       Date:  1987-08

10.  The production of arthritis in the guinea-pig by intra-articular reaction between lymphokines and inflammatory leucocytes.

Authors:  G A Limb; K A Brown; R A Wolstencroft; B A Ellis; D C Dumonde
Journal:  Br J Exp Pathol       Date:  1989-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.